Office of Technology Transfer and Development
What We Do
Partnering with NHLBI and OTTAD’s Client Institutes
OTTAD is the primary point of contact for technology development activities for the NHLBI, and six other NIH Institutes: National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institute on Deafness and Other Communication Disorders (NIDCD), National Institute of Environmental Health Sciences (NIEHS), National Institute of Nursing Research (NINR). A variety of mechanisms exists that allow NHLBI and OTTAD’s client Institutes to collaborate with external partners for research and development purposes.
Licensing Agreements
OTTAD recognizes the importance of converting basic science discoveries into public health benefits, by licensing research discoveries derived from the intramural and extramural laboratories of NHLBI and OTTAD’s client Institutes. If an entity is licensing either an unpatented material or a patented or patent-pending technology for commercial purposes, a Commercial Evaluation License, a Biological Materials License, or an Exclusive/Nonexclusive License is required. OTTAD recommends using OTTAD Technology Search, a live search engine for locating technologies developed in the labs NHLBI and OTTAD’s client Institutes by keyword or taxonomy classification. Please contact our Licensing and Patent Managers with questions about licensing opportunities.
Transactional Agreements
The Transactional Agreements negotiated by OTTAD include Confidential Disclosure Agreements (CDAs) and Material Transfer Agreements (MTAs). CDAs permit the transfer or exchange of proprietary information between parties. MTAs specify the transfer and use of research materials for internal use between parties. OTTAD will advise which agreement to use, depending on the goals of the project.
Collaborative Research Agreements
OTTAD uses three different collaborative research agreements to help industry and academia interact and partner with NIH laboratories and scientists to support technology development activities. These include Research Collaboration Agreements (RCAs), Cooperative Research and Development Agreements (CRADAs), and Clinical Trial Agreements (CTAs). OTTAD will advise which agreement to use, depending on the goals of the project. Please contact one of our Technology Development Specialists to answer any questions about Transactional or Collaborative Research Agreements.
Contact Office of Technology Transfer and Development
Office of Technology Transfer and Development, National Heart, Lung, and Blood Institute
31 Center Drive
Room 4A29, MSC2479
Bethesda, MD 20892-2479
United States